MEDICLIN presents preliminary figures for the 2024 financial year

EQS-News: MEDICLIN AG / Key word(s): Preliminary Results MEDICLIN presents preliminary figures for the 2024 financial year 27.02.2025 / 13:03 CET/CEST The issuer is solely responsible for the content of this announcement. Offenburg, February 27, 2024 MEDICLIN presents preliminary figures for the 2024 financial year MEDICLIN increases its group sales in 2024 by 2.6% to EUR 748.8 mill. Group operating result reaches EUR 53.5 mill. (previous year: EUR 12.7 mill.) Capacity utilisation in the post-acute segment above 86% in every quarter MEDICLIN generated group sales of EUR 748.8 mill. in the 2024 financial year (previous year: EUR 730.1 mill.). The group operating result reached EUR 53.5 mill. and was thus EUR 40.8 mill. higher than in the previous year (previous year: 2023: EUR 12.7 mill.). In 2023, the group operating result was heavily impacted by impairment of goodwill in the acute segment at EUR 33.1 mill. Sales growth and the group operating result are at the upper end of the annual forecast renewed in January 2025 (1.0% to 3.0% and EUR 48.0 to 54.0 mill.). Tino Fritz, CFO of MEDICLIN, comments: "The sales growth and the positive development of the group operating result underline our operating performance in the second half of 2024. The consolidated EBIT of EUR 53.5 mill. is the result of the great commitment of the entire MEDICLIN workforce.           Development in the segments In the post-acute segment, sales increased by 7.6% to EUR 485.4 mill. (previous year: EUR 451.2 mill.). An operating result of EUR 52.3 mill. was achieved (previous year: EUR 52.7 mill.), which corresponds to a decrease of EUR 0.4 mill. or 0.8%. The sales and earnings performance of the post-acute segment was also positively influenced by a contribution from the “Reha-Klinik am Sendesaal”, which was acquired in 2024. In the acute segment, sales totalling EUR 234.9 mill. were achieved (previous year: EUR 254.0 mill.). The decline in sales is mainly due to the sale of the former „MEDICLIN Herzzentrum Coswig“. The segment operating result amounted to EUR –0.6 mill. in 2024 after EUR –39.9 mill. in 2023. In 2023, it was heavily burdened by goodwill amortisation of EUR 33.1 mill. As part of a reorganisation of segment reporting, we have split the previous "Other Activities" segment into the two independent "Service" and "Nursing care" segments. This reorganisation enables us to respond more specifically to the specific requirements and growth opportunities in these areas. Sales in the nursing care segment rose to EUR 23.4 mill. in the reporting year (previous year: EUR 21.3 mill.), while the operating result in the nursing care segment totalled EUR 0.2 mill., as in the previous year. In the Service segment, sales increased by EUR 13.3 mill. to EUR 94.6 mill.. At EUR 1.7 mill., the segment operating result was up EUR 2.0 mill. on the previous year (previous year: EUR –0.3 mill.). Employees and investments The number of employees (calculated in full-time equivalents) averaged 6,889 in the 2024 reporting year (previous year: 7,016 full-time equivalents). MEDICLIN invested in the future of the Group in 2024 with gross investments totalling EUR 46.2 mill. (previous year: EUR 38.8 mill.).   Key figures - yoy comparison of the Group and the segments     in million € 2024 2023 Group     Group sales 748.8 730.1 Raw materials and consumables used 129.1 137.4 Staff costs 466.3 460.6 Depreciation and amortisation 50.3 86.0 Other operating expenses 71.6 70.0 Group operating result 53.5 12.7 Total consolidated result 24.9 –10.7 Cash flow from operative activities 80.6 78.0 Earnings per share in € (un-/diluted) 0.52 –0.23 Number of employees  (full time staff on average) 6,889 7,016 Segments     Post-acute     Sales 485.4 451.2 Segment operating result 52.2 52.7 Acute     Sales 234.9 254.0 Segment operating result –0.6 –39.9 Nursing care     Sales 23.4 21.3 Segment operating result 0.2 0.2 Service     Sales 94.6 81.3 Segment operating result 1.7 –0.3       (Due to arithmetical reasons, calculation differences may occur in the table above)     The Annual Report 2024 will be available from 28 March 2025 at www.mediclin.de in German and English. You are welcome to subscribe to the IR newsletter here to receive regular updates on all topics relevant to investors.   For more information: MEDICLIN Aktiengesellschaft Okenstraße 27 77652 Offenburg Germany Investor Relations Ender Gülcan Phone +49 781/488-326 ender.guelcan@mediclin.de www.mediclin.de   About MEDICLIN Aktiengesellschaft (Ticker: MED; WKN: 659 510) MEDICLIN includes 31 clinics, six care facilities and ten medical care centers. The Group has around 8,200 beds/care places and employs around 9,900 people. In a strong network, MEDICLIN offers the patients integrative care from the first visit to the doctor through the operation and subsequent rehabilitation to outpatient aftercare. Doctors, therapists and nurses work together in a carefully coordinated manner. MEDICLIN designs the care and support of people in need of care according to their individual needs and personal needs. MEDICLIN ─ a company of the Asklepios Group 27.02.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement. The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com

Language:	English
Company:	MEDICLIN AG
	Okenstraße 27
	77652 Offenburg
	Germany
Phone:	+49 (0)781 488-326
Fax:	+49 (0)781 488-184
E-mail:	ender.guelcan@mediclin.de
Internet:	www.mediclin.de
ISIN:	DE0006595101
WKN:	659510
Listed:	Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID:	2092787

End of News	EQS News Service